Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,258 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,258 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,258 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,258 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,258 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,258 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,258 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Feb 2026
Timothy J Jahnke Director
Sold on a plan
$902.88K 17,900 at 50.44
5.8%
Planned (10b5-1)
4 Feb 2026
Joo Mi Kim Chief Financial Officer
Sold on a plan 5×
$873.37K 6,799 at 128.46
7.1%
Planned (10b5-1)
4 Feb 2026
Terrance P. Coyne EVP & CFO · indirect
Sold on a plan 2×
$872.91K 20,163 at 43.29
46.8%
Planned (10b5-1)
4 Feb 2026
Sold on a plan
$810.00K 4,500 at 180.00
22.4%
Planned (10b5-1)
4 Feb 2026
Scott Farquhar Director · indirect
Sold on a plan 9×
$805.88K 7,665 at 105.14
2.6%
Planned (10b5-1)
4 Feb 2026
Michael Cannon-Brookes CEO, Co-Founder · indirect
Sold on a plan 9×
$805.88K 7,665 at 105.14
2.6%
Planned (10b5-1)
4 Feb 2026
Xingjuan Chao President and CEO
Sold on a plan 3×
$786.24K 39,000 at 20.16
5.1%
Planned (10b5-1)
4 Feb 2026
Richard A Hayne CEO & Chairman of the Board
Sold on a plan 2×
$783.28K 10,667 at 73.43
0.1%
Planned (10b5-1)
4 Feb 2026
Jeremy Stoppelman Chief Executive Officer
Sold on a plan 2×
$743.62K 30,000 at 24.79
3.0%
Planned (10b5-1)
4 Feb 2026
Lia Dean Pres, Banking & Prem. Products
Sold on a plan
$734.57K 3,284 at 223.68
4.5%
Planned (10b5-1)
4 Feb 2026
Richard A Hayne CEO & Chairman of the Board · indirect also filed by Margaret Hayne
Sold on a plan 2×
$685.33K 9,333 at 73.43
0.5%
Planned (10b5-1)
4 Feb 2026
Vanessa Allen Sutherland EVP, GC and Secretary
Sold on a plan
$659.10K 4,394 at 150.00
14.6%
Planned (10b5-1)
4 Feb 2026
Chan Henry Lee SVP, General Counsel
Sold on a plan 2×
$580.20K 1,660 at 349.52
100%
Sold half or more
4 Feb 2026
Aghili Naseem Sagati General Counsel
Sold on a plan 7×
$529.03K 3,921 at 134.92
1.2%
Planned (10b5-1)
4 Feb 2026
Bryan Dechairo Chief Operating Officer
Sold on a plan 8×
$510.87K 5,961 at 85.70
100%
Sold half or more
4 Feb 2026
Peter C Farrell Director
Sold on a plan
$502.62K 2,000 at 251.31
3.0%
Planned (10b5-1)
4 Feb 2026
Sold on a plan
$493.03K 28,002 at 17.61
0.3%
Planned (10b5-1)
4 Feb 2026
James S Mahan III Chief Executive Officer · indirect
Sold on a plan 2×
$418.96K 10,000 at 41.90
0.3%
Planned (10b5-1)
4 Feb 2026
Leah Tate SVP - HR
Sold on a plan
$384.02K 2,954 at 130.00
10.6%
Planned (10b5-1)
4 Feb 2026
Carl Dambkowski Chief Medical Officer
Sold on a plan 5×
$361.86K 5,500 at 65.79
2.5%
Planned (10b5-1)
4 Feb 2026
Hunter C Smith Chief Financial Officer
Sold on a plan 3×
$344.15K 3,247 at 105.99
2.5%
Planned (10b5-1)
4 Feb 2026
Alexander Cumbo President and CEO
Sold on a plan
$315.09K 48,913 at 6.44
18.1%
Planned (10b5-1)
4 Feb 2026
Michael S Williams Chief Executive Officer
Sold on a plan
$291.81K 13,713 at 21.28
2.0%
Planned (10b5-1)
4 Feb 2026
Gary A Ogilby Senior VP & Corp Controller
Sold on a plan
$272.55K 435 at 626.56
12.0%
Planned (10b5-1)
4 Feb 2026
Patrick Burnett See Remarks
Sold on a plan
$252.75K 9,794 at 25.81
10.8%
Planned (10b5-1)
4 Feb 2026
Hunter Middleton Chief Product Officer
Sold on a plan
$212.81K 85,044 at 2.50
11.5%
Planned (10b5-1)
4 Feb 2026
Melissa Thomas EVP, Chief Financial Officer
Sold on a plan
$206.94K 7,944 at 26.05
4.7%
Planned (10b5-1)
4 Feb 2026
Erika Ashley Fisher Chief Legal Officer
Sold on a plan
$200.17K 841 at 238.01
7.7%
Planned (10b5-1)
4 Feb 2026
Sold on a plan
$164.80K 40,000 at 4.12
4.2%
Planned (10b5-1)
4 Feb 2026
Jack Bendheim President and CEO · indirect
Sold on a plan
$144.86K 3,520 at 41.15
6.7%
Planned (10b5-1)
4 Feb 2026
David T Howton Chief Operating Officer
Sold on a plan
$121.71K 18,894 at 6.44
16.2%
Planned (10b5-1)
4 Feb 2026
Barry D Quart Director
Sold on a plan
$117.14K 2,602 at 45.02
17.2%
Planned (10b5-1)
4 Feb 2026
Sold on a plan
$107.99K 10,000 at 10.80
0.5%
Planned (10b5-1)
4 Feb 2026
Randall K Fields Chief Executive Officer · indirect
Sold on a plan 2×
$100.14K 9,500 at 10.54
7.6%
Planned (10b5-1)
4 Feb 2026
Elizabeth E Reed Chief Legal Officer and GC
Sold on a plan 2×
$96.36K 2,994 at 32.18
2.8%
Planned (10b5-1)
4 Feb 2026
Kevin Tan CFO & Treasurer
Sold on a plan
$95.23K 14,783 at 6.44
13.6%
Planned (10b5-1)
4 Feb 2026
Gabriel Brooks Chief Medical Officer
Sold on a plan
$81.27K 12,616 at 6.44
13.0%
Planned (10b5-1)
4 Feb 2026
Jessie Hanrahan Chief Regulatory Officer
Sold on a plan
$79.54K 12,348 at 6.44
14.9%
Planned (10b5-1)
4 Feb 2026
Paul Herzich Chief Technology Officer
Sold on a plan
$70.25K 10,905 at 6.44
13.6%
Planned (10b5-1)
4 Feb 2026
Andrew G Inglis Chairman and CEO
Sold on a plan
$63.37K 44,628 at 1.42
1.0%
Planned (10b5-1)
4 Feb 2026
Jula Inrig Chief Medical Officer
Sold on a plan 2×
$57.30K 1,779 at 32.21
1.7%
Planned (10b5-1)
4 Feb 2026
Christopher R. Cline Chief Financial Officer
Sold on a plan 2×
$56.17K 1,745 at 32.19
1.5%
Planned (10b5-1)
4 Feb 2026
Ilan Ganot Director · indirect
Sold on a plan
$46.41K 7,205 at 6.44
22.2%
Planned (10b5-1)
4 Feb 2026
Kristopher R Westbrooks President & COO
Sold on a plan
$45.28K 2,128 at 21.28
1.1%
Planned (10b5-1)
4 Feb 2026
Ned S Holmes Director · indirect
Sold on a plan 5×
$43.57K 600 at 72.62
1.4%
Planned (10b5-1)
4 Feb 2026
Jeanette Sellers SVP of Accounting
Sold on a plan
$39.84K 2,182 at 18.26
4.8%
Planned (10b5-1)
4 Feb 2026
Kyle Piskel Chief Financial Officer
Sold on a plan
$39.60K 2,145 at 18.46
1.0%
Planned (10b5-1)
4 Feb 2026
Ned S Holmes Director
Sold on a plan 2×
$36.32K 500 at 72.64
0.6%
Planned (10b5-1)
4 Feb 2026
Steven Yi See Remarks
Sold on a plan
$35.75K 4,000 at 8.94
0.1%
Planned (10b5-1)
Showing 17,551–17,600 of 23,258. ← Newer Page 352 of 466 Older →